Amoy Diagnostics Co (SZSE:300685) Ending Cash Position : ¥324 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Amoy Diagnostics Co Ending Cash Position?

Amoy Diagnostics Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥324 Mil.

Amoy Diagnostics Co's quarterly Ending Cash Position increased from Sep. 2023 (¥195 Mil) to Dec. 2023 (¥201 Mil) and increased from Dec. 2023 (¥201 Mil) to Mar. 2024 (¥324 Mil).

Amoy Diagnostics Co's annual Ending Cash Position increased from Dec. 2021 (¥231 Mil) to Dec. 2022 (¥244 Mil) but then declined from Dec. 2022 (¥244 Mil) to Dec. 2023 (¥201 Mil).

Amoy Diagnostics Co Ending Cash Position Historical Data

The historical data trend for Amoy Diagnostics Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amoy Diagnostics Co Ending Cash Position Chart

Amoy Diagnostics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

498.39

361.56

230.74

243.59

201.08

Amoy Diagnostics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															205.80	227.55	195.34	201.08	323.75

Amoy Diagnostics Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Amoy Diagnostics Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	243.591	+	-42.513
	=	201

Amoy Diagnostics Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	201.078	+	122.672
	=	324

Amoy Diagnostics Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Amoy Diagnostics Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Amoy Diagnostics Co (SZSE:300685) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Amoy Diagnostics Co Ltd (SZSE:300685) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

39 Dingshan Road, Haicang District, Xiamen, CHN, 361027

Website

http://www.amoydx.com

Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnostics for oncology precision medicine. It provides diagnostic products and services for medicine development and clinical oncology practice. The company's products include gene mutation, nucleic acid extraction, and molecular diagnostic kits comprising EGFR, RAS, ALK, BRAF, PIK3CA, and ROS1 testing kits.

Executives

Ruan Li	Directors, executives
Zheng Hui Bin	Directors, executives
Chen Ying	Directors, executives
Luo Jie Min	Executives
Zhu Guan Shan	Directors, executives
Yang Shou Qian	Securities Affairs Representative
Zhou Wen Gang	Executives
Zhou Xue Lin	Independent director
Hu Xu Bo	Director

Amoy Diagnostics Co (SZSE:300685) Headlines

No Headlines